JP2023552757A5 - - Google Patents

Info

Publication number
JP2023552757A5
JP2023552757A5 JP2023533347A JP2023533347A JP2023552757A5 JP 2023552757 A5 JP2023552757 A5 JP 2023552757A5 JP 2023533347 A JP2023533347 A JP 2023533347A JP 2023533347 A JP2023533347 A JP 2023533347A JP 2023552757 A5 JP2023552757 A5 JP 2023552757A5
Authority
JP
Japan
Prior art keywords
composition
cannabinoid
item
compound
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023533347A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023552757A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/061206 external-priority patent/WO2022119840A1/en
Publication of JP2023552757A publication Critical patent/JP2023552757A/ja
Publication of JP2023552757A5 publication Critical patent/JP2023552757A5/ja
Pending legal-status Critical Current

Links

JP2023533347A 2020-12-01 2021-11-30 カンナビノイドベースの治療薬のための方法および組成物 Pending JP2023552757A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202063119842P 2020-12-01 2020-12-01
US202063119862P 2020-12-01 2020-12-01
US63/119,842 2020-12-01
US63/119,862 2020-12-01
PCT/US2021/061206 WO2022119840A1 (en) 2020-12-01 2021-11-30 Methods and compositions for cannabinoid-based therapeutics

Publications (2)

Publication Number Publication Date
JP2023552757A JP2023552757A (ja) 2023-12-19
JP2023552757A5 true JP2023552757A5 (https=) 2024-12-10

Family

ID=81853512

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023533347A Pending JP2023552757A (ja) 2020-12-01 2021-11-30 カンナビノイドベースの治療薬のための方法および組成物

Country Status (4)

Country Link
US (1) US20240148760A1 (https=)
EP (1) EP4255405A4 (https=)
JP (1) JP2023552757A (https=)
WO (1) WO2022119840A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4208157A1 (en) 2020-09-04 2023-07-12 Elanco Us Inc. Palatable formulations
US20240207338A1 (en) * 2021-04-30 2024-06-27 Progressive Therapeutics Inc Ketamine and cannabis for the treatment of emotional disorders
WO2023183618A1 (en) * 2022-03-25 2023-09-28 Ojai Energetics Pbc Psychedelic compositions and methods for forming the same
CN116251091B (zh) * 2023-01-03 2025-04-15 中国中医科学院中药研究所 一种预防和/或治疗神经病理性疼痛或并发症的药物组合物
US12263241B1 (en) 2023-11-27 2025-04-01 J.D.I.P., Llc Cannabis compositions, oral products, and methods of making same
KR20260023164A (ko) * 2024-08-09 2026-02-20 한국 한의학 연구원 헴프 추출물을 유효성분으로 함유하는 전립선 비대증의 예방, 개선 또는 치료용 조성물

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4963364A (en) * 1989-04-10 1990-10-16 Fox Sidney W Microencapsulated antitumor agent
EP1792622A1 (en) * 2005-11-11 2007-06-06 GPC Biotech AG Anti-proliferative combination therapy comprising a platinum-based chemotherapeutic agent and EGFR inhibitors or pyrimidine analogues
JP2011530511A (ja) * 2008-08-05 2011-12-22 メルク・シャープ・エンド・ドーム・コーポレイション 治療用化合物
US20180303791A1 (en) * 2014-11-26 2018-10-25 One World Cannabis Ltd Synergistic use of cannabis for treating multiple myeloma
US10350165B2 (en) * 2014-12-12 2019-07-16 Ojai Energetics Pbc Methods and systems for forming stable droplets
MX395015B (es) * 2014-12-12 2025-03-24 Ojai Energetics Pbc Composiciones microencapsuladas de cannabinoides
EP3247402A4 (en) * 2015-01-21 2018-08-08 Willinsky, Michael Composition and methods to improve stability, dosing, pharmacodynamics and product shelf life of endocannabinoids, phytocannabinoids and synthetic cannabinoids delivered by nasal inhaler
GB2553139A (en) * 2016-08-25 2018-02-28 Gw Res Ltd Use of cannabinoids in the treatment of multiple myeloma
US10688191B2 (en) * 2018-01-19 2020-06-23 Hr Biomed, Llc Delivery of a chemotherapy agent across the blood-brain barrier
CA3095970A1 (en) * 2018-04-04 2019-10-10 Jay Pharma Inc. Combination of a cannabinoid and a chemotheraopeutic agent for the treatment of breast cancer
EP3946315A4 (en) * 2019-03-28 2023-04-12 Scicann Therapeutics Inc. CANNABINOID COMPOSITIONS AND USE THEREOF

Similar Documents

Publication Publication Date Title
JP2023552757A5 (https=)
Martín Giménez et al. Nanomedicine applied to cardiovascular diseases: latest developments
Garraud et al. Wound healing: time to look for intelligent,‘natural’immunological approaches?
Duan et al. The effects of curcumin post-treatment against myocardial ischemia and reperfusion by activation of the JAK2/STAT3 signaling pathway
MXPA05010937A (es) Derivados de fenilalanina n-(1,3-tiazol-2-il)amino)carbonil)fenil)sulfonil) y compuestos relacionados para el tratamiento de diabetes.
MX2015000830A (es) Derivados heterociclicos nitrogenosos y su aplicacion en farmacos.
JP2019507781A5 (https=)
WO2008074997A8 (en) Pyridine benzamides and pyrazine benzamides used as pkd inhibitors
EA200900264A1 (ru) Композиции флибансерина и способ их приготовления
MX2009008084A (es) Derivados de 5,6,7,8-tetrahidropteridina como inhibidores de hsp90.
TW200630327A (en) Substituted phenylalkanoic acids
WO2009066060A3 (en) 4-substituted-6-isopropyl-benzene-1,3-diol compounds and their use
WO2010042489A3 (en) Aminoquinoline derived heat shock protein 90 inhibitors, methods of preparing same, and methods for their use
JP2019502716A5 (https=)
WO2011149964A3 (en) Methods for treating or preventing vascular graft failure
JP2017503014A5 (https=)
EP4279128A3 (en) Novel antibody binding to tfpi and composition comprising the same
WO2022079290A3 (en) Heterocyclic cullin ring ubiquitin ligase compounds and uses thereof
JP2011527301A5 (https=)
MALAYERI et al. A comparison of the effects of quercetin hydrate with those of vitamin E on the levels of IL-13, PDGF, TNF-α, and INF-γ in bleomycin-induced pulmonary fibrosis in rats
JP2013518914A5 (https=)
JP2018524306A5 (https=)
BR112012022209A2 (pt) composições farmacêuticas compreendendo monoterpenos
JP2017536380A5 (https=)
JP2018537987A5 (https=)